An experience of the use of cell culture-derived influenza vaccines in an influenza vaccination campaign;Experiencia de la utilización de vacunas antigripales desarrolladas a partir de cultivos celulares en una campaña de vacunación

Gaceta Sanitaria

Volumn 28, Issue 1, 2014, Pages 88-89

  Pérez Rubio, Alberto ^a   Bouza, Jose María Eiros ^b  

^a Castile and León   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CELL CULTURE; HUMAN; INFLUENZA, HUMAN; PREVENTIVE HEALTH SERVICE; SPAIN; VACCINATION;

CELLS, CULTURED; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; INFLUENZA, HUMAN; SPAIN; VACCINATION;

EID: 84891495439     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1016/j.gaceta.2013.05.003     Document Type: Letter

References (5)

1. Robertson J.S. Clinical influenza virus and the embryonated chicken's egg. Rev Med Virol 1993, 3:97-106.
2. Lu B., Zhou H., Chan W., et al. Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04(H3N2) increase virus growth in embryonated chicken eggs. Vaccine 2006, 24:6691-6693.
3. Mabrouk T., Ellis R.W. Influenza vaccine technologies and the use of the cell-culture process (cell-culture influenza vaccine). Dev Biol (Basel) 2002, 110:125-134.
4. Szymczakiewicz-Multanowska A., Groth N., Bugarini R., et al. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. J Infect Dis 2009, 200:841-848.
5. Ficha técnica Optaflu®. (Consultado el 26/03/2013.) Disponible en: http://www.aemps.gob.es/cima/fichasTecnicas.do%3Fmetodo=buscar.